ARCHIVES

Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

General Says HHS Shift of Breast Cancer funds Could Leave Army in “Untenable Position”

March 12, 1993

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

October 18, 2002

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

Children, Parents Differ In Decisionmaking On Cancer Treatment, Survivor Study Finds

July 29, 2005

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

ASCO Releases Guideline On Use Of Growth Factors

May 26, 2006